Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.310
+0.080 (1.89%)
At close: Nov 26, 2025, 4:00 PM EST
4.300
-0.010 (-0.23%)
After-hours: Nov 26, 2025, 4:42 PM EST
Strata Critical Medical Revenue
Strata Critical Medical had revenue of $49.30M in the quarter ending September 30, 2025, with 36.70% growth. This brings the company's revenue in the last twelve months to $268.62M, up 70.11% year-over-year. In the year 2024, Strata Critical Medical had annual revenue of $248.69M with 10.44% growth.
Revenue (ttm)
$268.62M
Revenue Growth
+70.11%
P/S Ratio
1.29
Revenue / Employee
$866,510
Employees
310
Market Cap
371.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 248.69M | 23.51M | 10.44% |
| Dec 31, 2023 | 225.18M | 79.06M | 54.11% |
| Dec 31, 2022 | 146.12M | 78.96M | 117.58% |
| Dec 31, 2021 | 67.16M | 16.63M | 32.92% |
| Sep 30, 2021 | 50.53M | 27.09M | 115.61% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SRTA News
- 6 days ago - Strata Critical Medical, Inc. (SRTA) Analyst/Investor Day Transcript - Seeking Alpha
- 10 days ago - Strata Critical Medical Hosts 2025 Investor Day; Provides 2026 and Medium-Term Financial Guidance - GlobeNewsWire
- 17 days ago - Strata Critical Medical, Inc. (SRTA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Strata Critical Medical Announces Third Quarter 2025 Results - GlobeNewsWire
- 7 weeks ago - Strata Critical Medical Announces Date for Third Quarter Ending September 30, 2025 Earnings Release Conference Call - GlobeNewsWire
- 2 months ago - Strata Announces 2025 Investor Day - GlobeNewsWire
- 2 months ago - OrganOx metra® Receives FDA Approval for Operation During Air Transport, Expanding Access to Life-Saving Liver Perfusion Technology - GlobeNewsWire
- 2 months ago - Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services - GlobeNewsWire